KMTS: COHEN RAYMOND W discloses a sale

By AlphaYouPublished Oct 1, 2026Form 4

Stocks in this disclosure

Reported activity

COHEN RAYMOND W

Reporting filer

COHEN RAYMOND W reported Sale in KESTRA MEDICAL TECHNOLOGIES, LTD.: 3330 units of Common Shares, dated 2026-09-30. The full Form 4 contains 1 transaction entry.

Disclosed: Oct 1, 2026

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Common Shares	COHEN RAYMOND W	2026-09-30	S	Sale	3330	29.2805	54,790	1 day	Filed terms security Title: Common Shares transaction Date: 2026-09-30 transaction Form Type: 4 transaction Code: S equity Swap Involved: false id: F1 transaction Shares: 3330 transaction Price Per Share: 29.2805 id: F2 transaction Acquired Disposed Code: D shares Owned Following Transaction: 54790 direct Or Indirect Ownership: D

Common Shares

Owner: COHEN RAYMOND W
Date: 2026-09-30
Code: S
Action: Sale
Quantity: 3330
Price: 29.2805
Following holdings: 54,790
Reporting delay: 1 day
Filed terms and references: Filed terms
security Title: Common Shares
transaction Date: 2026-09-30
transaction Form Type: 4
transaction Code: S
equity Swap Involved: false
id: F1
transaction Shares: 3330
transaction Price Per Share: 29.2805
id: F2
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 54790
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
COHEN RAYMOND W: Director.
F1: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
F2: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $29.2800 to $29.2900. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Common Shares

COHEN RAYMOND W

2026-09-30

Sale

3330

29.2805

54,790

1 day

Filed terms

security Title: Common Shares
transaction Date: 2026-09-30
transaction Form Type: 4
transaction Code: S
equity Swap Involved: false
id: F1
transaction Shares: 3330
transaction Price Per Share: 29.2805
id: F2
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 54790
direct Or Indirect Ownership: D

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

COHEN RAYMOND W: Director.

F1: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

F2: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $29.2800 to $29.2900. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.